irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial.

Name: irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial.
Author: Pignon, Jean-Christophe

irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial. — المؤلف: Pignon, Jean-Christophe — Clinical cancer research : an official journal of the American Association for Cancer Research 20200511

المؤلف: Pignon, Jean-Christophe
النشر: Clinical cancer research : an official journal of the American Association for Cancer Research 20200511
الوصف: 2174-2184 p.
الموضوعات: Adult؛ Aged؛ Aged, 80 and over؛ Antineoplastic Agents, Immunological؛ Biomarkers, Tumor؛ CD8-Positive T-Lymphocytes؛ Carcinoma, Renal Cell؛ Female